Inhibition of HIV Entry by Targeting the Envelope Transmembrane Subunit gp41

E-ISSN： 1873-4251|14|3|283-294

ISSN： 1570-162X

Source： Current HIV Research, Vol.14, Iss.3, 2016-05, pp. : 283-294

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development of Anti-HIV Agents Targeting Dynamic Supramolecular Mechanism: Entry and Fusion Inhibitors Based on CXCR4/CCR5 Antagonists and gp41-C34-Remodeling Peptides

Current HIV Research, Vol. 3, Iss. 4, 2005-10 ,pp. : 289-301

Bentham Science Publishers

Access to resources Recommend Favorite

CD4-Induced Epitopes in the HIV Envelope Glycoprotein, Gp120

Current HIV Research, Vol. 5, Iss. 6, 2007-11 ,pp. : 561-571

Bentham Science Publishers

Access to resources Recommend Favorite

Progress Towards the Development of a HIV-1 gp41-Directed Vaccine

Current HIV Research, Vol. 2, Iss. 2, 2004-01 ,pp. : 193-204

Bentham Science Publishers

Access to resources Recommend Favorite

Relative Dominance of Env-gp41-Specific Cytotoxic T Lymphocytes Responses in HIV-1 Advanced Infection

Current HIV Research, Vol. 6, Iss. 3, 2008-05 ,pp. : 239-245

Bentham Science Publishers

Access to resources Recommend Favorite

Unexpected Molecular Mimicry among Peptides MHC Class II, Blood-Clotting Factor X, and HIV-1 Envelope Glycoprotein GP120

By Tishkoff G.H. Hunt L.T.

Thrombosis Research, Vol. 98, Iss. 4, 2000-05 ,pp. : 343-346

Elsevier

Access to resources Recommend Favorite